ING4 as a member of inhibitor of growth (ING) tumor suppressor family has potent inhibitory effects on a variety of tumors. Interleukin-24 (IL-24), a cytokine-tumor suppressor, also shows broad-spectrum and tumor-specific antitumor activities. In this report, we constructed an ING4/IL-24 bicistronic adenovirus (Ad-ING4-IL-24) and assessed its combined effect on in vitro and in vivo A549 human non-small cell lung cancer cells. We demonstrated that ING4 and IL-24 combination treatment by adenovirusmediated ING4 and IL-24 coexpression induced additive growth suppression and apoptosis as well as an overlapping effect on upregulation of P21, P27, Fas, Bax and cleaved Caspases-8, 9, 3 and downregulation of Bcl-2 in in vitro A549 lung carcinoma cells. Moreover, Ad-ING4-IL-24 treatment additively inhibited in vivo A549 lung carcinoma subcutaneous (s.c.) xenografted tumor growth and reduced CD34 and microvessel density in A549 xenografted tumors in athymic nude mice. The enhanced antitumor activity elicited by Ad-ING4-IL-24 was closely associated with the coordinate activation of extrinsic and intrinsic apoptotic pathways and additive inhibition of tumor angiogenesis. Thus, our results indicate that cancer gene therapy combining two or more tumor suppressors such as ING4 and IL-24 may constitute a novel and effective therapeutic strategy for lung carcinoma and other cancers.
Introduction
Lung cancer is one of the most prevalent cancers among men and women, which is the leading cause of cancerrelated deaths worldwide. 1 There are two major types of lung cancer including small cell lung cancer and non-small cell lung cancer (NSCLC). 2 NSCLC accounts for about 85% of all cases of lung cancer. 3 Conventional treatments for lung cancer involve surgery, chemotherapy and radiotherapy. Unfortunately, the poor 5-year survival rate of patients with lung cancer (only 14%) has not been improved by current treatments primarily due to a propensity to metastasize as well as resistance to chemotherapy and radiation. 4 Thus, novel therapeutic modalities to improve the prognosis of lung cancer are urgently needed. Cancer gene therapy represents a new and promising therapeutic modality for cancers. However, lung cancer is characterized by a multistep process of genetic and molecular changes in oncogenes and tumor suppressor genes, 2 which limit efficacy of a single gene-mediated lung cancer therapy due to the difficulty to find a pivotal gene conferring its occurrence and progression. Therefore, multigene-based combination therapy may be an effective practice in lung cancer gene therapy.
ING4, a member of inhibitor of growth (ING) family, has recently attracted much attention as a strong candidate tumor suppressor. ING4 is frequently downregulated or deleted in a variety of tumors, which contributes to tumor progression and prognosis. [5] [6] [7] [8] ING4 can significantly induce tumor growth suppression in different tumor types via induction of cell-cycle alteration and apoptosis and inhibition of tumor angiogenesis by repressing nuclear factor kB and hypoxia-inducible factor-1a activity and consequently reducing production of proangiogenic factors. 5, [9] [10] [11] [12] [13] [14] ING4 can also enhance chemosensitivity to DNA-damage agents such as doxorubicin and etoposide in HepG2 hepatocarcinoma cells. 10 Furthermore, ING4 can exhibit remarkable inhibitory effect on tumor cell spreading, migration and invasion via colocalization and interaction with liprin a1 at lamellipodia 15 and downregulation of matrix metalloproteinase-2 and matrix metalloproteinase-9. 11, 16 In addition, ING4 can suppress the loss of contact inhibition elicited by myelocytomatosis viral related oncogene, neuroblastoma derived or myelocytomatosis viral oncogene homolog. 17 The other tumor suppressor melanoma differentiation-associated gene-7/ interleukin-24 (mda-7/IL-24), originally identified in human melanoma cells treated with interferon-b and mezerein by subtraction hybridization, 18 is a unique cytokine-tumor suppressor belonging to IL-10 family. 19 Extensive studies have shown that IL-24 displays ubiquitous antitumor property and tumor-specific killing activity in a broad spectrum of cancer cells but not in normal cells. 20 IL-24 can also inhibit tumor angiogenesis through directly suppressing vascular endothelial cell differentiation and migration 21, 22 and indirectly downregulating production of proangiogenic factors, 21, 23, 24 and repress tumor cell invasion and migration via downregulation of phosphatidylinositol 3-kinase, focal adhesion kinase and matrix metalloproteinase-2, 9. 25 In addition, IL-24 can exert a potent immunostimulatory activity and enhance antitumor immunity. 26 Interestingly, IL-24 can exhibit a profound bystander antitumor activity and augment its antitumor therapeutic potential. 20 Thus, ING4 and IL-24 as promising tumor suppressors negatively modulate tumor growth via multiple pathways.
The therapeutic potential of a conjunction of ING4 and IL-24 for cancers has not been reported. Based on the antitumor features of ING4 and IL-24, we hypothesized that the combination treatment of ING4 and IL-24 tumor suppressors would elicit an enhanced antitumor efficacy. Therefore, in this study, we constructed an ING4/IL-24 bicistronic adenovirus harboring ING4 and IL-24 double tumor suppressor genes (Ad-ING4-IL-24) and were interested in evaluating its combined therapeutic effect on A549 human NSCLC cells in vitro and in vivo in an athymic nude mouse model and also elucidating its underlying molecular mechanism.
Materials and methods

Vectors, cell lines, reagents and mice
The adenoviral transfer plasmid pAdTrack-CMV expressing green fluorescent protein and Ad5E1-and E3-deleted backbone plasmid pAdEasy-1, 27 BJ5183 bacteria and QBI-293A human embryonic kidney cell line were kindly provided by Dr Jiang Zhong (Department of Microbiology, College of Life Science, Fudan University, Shanghai, China). The pGEZ-Term retroviral plasmid was kindly provided by Dr Yongjing Chen (Biotechnology Institute, Soochow University, Suzhou, China). The A549 (wild-type p53) human NSCLC cell line was purchased from the American Type Culture Collection (Shanghai, China). The QBI-293A and A549 cells were cultured in RPMI-1640 (Gibco, Shanghai, China) supplemented with 10% fetal bovine serum (Hyclone, Shanghai, China), respectively. The Lipofectamine2000, Trizol and reverse transcriptase MuMLV were purchased from Invitrogen (Shanghai, China). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) kit was purchased from Sigma (Shanghai, China). The Annexin V-PE/7-AAD apoptosis detection kit was purchased from BD Biosciences (Shanghai, China). The in situ cell death detection kit was purchased from Roche Applied Science (Shanghai, China). The polyclonal anti-ING4 antibody was purchased from Abcam (Shanghai, China). The monoclonal anti-IL-24 antibody and human IL-24 enzyme-linked immunosorbent assay (ELISA) kit were purchased from R&D Systems (Shanghai, China). The antibodies specific for P53, P21, P27, Fas, Bcl-2, Bax, Caspase-8, Caspase-9, Caspase-3, CD34 and b-actin were purchased from Cell Signaling (Shanghai, China). The SuperEnhanced chemiluminescence detection kit was purchased from Applygen Technologies (Beijing, China). The UltraSensitiveTM SP kit was purchased from Maixin (Fuzhou, China). The male athymic nude mice were purchased from Shanghai Experimental Animal Center (Shanghai, China) and maintained in the animal facility at Soochow University according to the animal research committee's guidelines of Soochow University.
Preparation of an internal ribosome entry site-mediated ING4/IL-24 bicistronic adenovirus We constructed a recombinant ING4/IL-24 bicistronic adenovirus coexpressing ING4 and IL-24 double tumor suppressor genes using internal ribosome entry site (IRES) element. 28 Briefly, the IRES fragments were amplified by PCR using pGEZ-Term plasmids carrying IRES element as templates and IRES-F (5 0 -acc gtc gac aat tcc gcc cct ctc cct ccc ccc ccc cta a-3 0 ) and IRES-R (5 0 -gac gcg gcc gct tat cat cgt gtt ttt caa agg aaa acc ac-3 0 ) as primers, and the ING4 and IL-24 cDNA fragments were amplified by PCR using pcDNA3-ING4 or pcDNA3-IL-24 plasmids as templates and primers specific for ING4 (ING4-F, 5 0 -tag aga tct acc atg gct gct ggg atg tat ttg g-3 0 and ING4-R, 5 0 -acc gtc gac cct att tct tct tcc gtt ctt g-3 0 ) or IL-24 (IL-24-F, 5 0 -gca ctc gag acc atg aat ttt caa cag agg ctg ca-3 0 and IL-24-R, 5 0 -gct tct aga tca gag ctt gta gaa ttt ctg-3 0 ) as primers. The ING4, IRES and IL-24 fragments were then subcloned into pAdTrack-CMV transfer plasmid expressing green fluorescent protein at BglII, SalI; SalI, NotI; XhoI, XbaI sites, respectively. After homologous recombination with Ad5E1-and E3-deleted backbone plasmid pAdEasy-1 in BJ5183 bacteria, the recombinant adenovirus Ad-ING4-IRES-IL-24 (termed Ad-ING4-IL-24) was subsequently produced and amplified in QBI-293A cells, and purified by cesium chloride density-gradient ultracentrifugation as described previously. 27 The Ad-IRES (Ad), Ad-ING4-IRES (Ad-ING4) and Ad-IRES-IL-24 (Ad-IL-24) used as control adenoviruses were similarly prepared as described above. The titer of purified adenoviruses was determined using gene transfer unit (GTU) method by calculating the number of the reporter gene green fluorescent protein-expressing QBI-293A cells within 18 h after adenoviral infection under fluorescence microscopy. Accordingly, the ratio of infectious adenovirus (GTU) to target cells is called multiplicity of infection (MOI) in our study.
Reverse transcription (RT)-PCR analysis
The adenovirus-mediated ING4 and IL-24 transcriptional expression in A549 human lung carcinoma cells were determined by RT-PCR analysis. Briefly, the A549 tumor cells (5 Â 10 6 ) were infected with Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 or Ad used as a blank adenovirus control at the optimal MOI of 100 as previously described, 11 or without adenovirus (phosphate-buffered saline (PBS) control), respectively. After 24 h treatment, the infected and uninfected A549 tumor cells were collected, and total cellular RNA was extracted with Trizol. The first-strand cDNA was then reversely transcribed with RNA (2 mg) as a template and Oligo d(T) 18 (0.5 mg) as a primer using reverse transcriptase MuMLV (50 U). The PCR was carried out using cDNA as a template and primers specific for ING4, IL-24, ING4-IRES-IL-24 and housekeep gene b-actin (an internal control) as primers, respectively. The RT-PCR products were then analyzed by 1% agarose gel electrophoresis.
ELISA analysis
The adenovirus-mediated secretory expression of IL-24 in A549 human lung carcinoma cells was detected by ELISA analysis. Briefly, the A549 tumor cells (5 Â 10 6 ) were infected with Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 or Ad used as a blank adenovirus control at the optimal MOI of 100 or without adenovirus (PBS control) in 10 ml medium, respectively. After 24 h treatment, the cellular culture supernatants generated from Ad-ING4-IL-24-, Ad-ING4-, Ad-IL-24-or Ad-infected and uninfected A549 tumor cells were harvested, and the amount of IL-24 in above culture supernatants was analyzed by ELISA using human IL-24 ELISA kit according to manufacturer's instruction.
Cell viability assay
The in vitro cytotoxic effect of Ad-ING4-IL-24 on A549 human lung carcinoma cells was evaluated by MTT assay. Briefly, the A549 tumor cells were dispensed into 96-well culture plates at 1 Â 10 4 cells per well, respectively. After 24 h incubation at 37 1C, the A549 tumor cells were infected with Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 or Ad used as a blank adenovirus control at the optimal MOI of 100 or without adenovirus (PBS control), and cultured for the indicated time periods (0-4 days). Before treatment and at different time points after treatment, the viability of A549 tumor cells was analyzed using MTT kit according to company's protocol.
Flow cytometric analysis of apoptosis
The A549 human lung carcinoma cells (1 Â 10 6 ) were cultured with Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 or Ad at the optimal MOI of 100 or without adenovirus (PBS control), respectively. After 48 h, the treated and untreated A549 tumor cells were harvested and washed in cold PBS for flow cytometric analysis of apoptosis using Annexin V-PE/7-AAD apoptosis detection kit following the manufacturer's instruction. Briefly, the treated and untreated A549 tumor cells (1 Â 10 5 ) were incubated with 5 ml Annexin V-PE and 5 ml 7-AAD in 100 ml of 1 Â Annexin V binding buffer at room temperature. After 15 min incubation, 400 ml of 1 Â binding buffer was added and the apoptotic cells were then analyzed by flow cytometry. In addition, the treated and untreated A549 tumor cells were subjected to flow cytometric analysis of apoptosis by TUNEL assay using in situ cell death detection kit according to company's protocol. Briefly, the above treated and untreated A549 tumor cells (2 Â 10 6 ) were fixed with fixing solution (4% paraformaldehyde in PBS), permeabilized with permeabilization solution (0.1% Triton X-100 in 0.1% sodium citrate) and then stained with TUNEL reaction mixture in the dark at 37 1C for 1 h. After washes three times with PBS, the DNA fragmentation in A549 tumor cells was analyzed by flow cytometry according to fluorescein expression.
Western blot analysis
The A549 human lung carcinoma cells (5 Â 10 6 ) were infected with Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 or Ad at the optimal MOI of 100 or without adenovirus (PBS control), respectively. After 24 h treatment, the infected and uninfected A549 tumor cells were collected, washed with cold PBS and lysed in lysis buffer (1 Â 10 7 cells per 1 ml lysis buffer) for preparation of total cellular lysate using mammalian cell lysis kit (Sigma, Santa Clara, CA). The protein concentration was determined by BCA protein assay using spectrophotometer. Total cellular lysates (100 mg per lane) were then resolved by 12% sulfate-polyacrylamide gel electrophoresis and subsequently transferred onto a polyvinylidene difluoride membrane. Blocked with 5% (w/v) non-fat dry milk in Tris-buffered saline containing 0.05% Tween-20, the membrane was incubated with a panel of primary antibodies specific for ING4, IL-24, P53, P21, P27, Fas, Bcl-2, Bax, Caspase-8, Caspase-9, Caspase-3 and b-actin (an internal control) in blocking solution for 1 h followed by incubation with horseradish peroxidase-conjugated secondary antibody for another 1 h. The membrane was then washed and developed using SuperEnhanced chemiluminescence detection kit according to the manufacturer's instruction. The protein bands were visualized after exposure of the membranes to Kodak X-ray film.
Animal studies
The male athymic nude mice were subcutaneously (s.c.) inoculated on their armpits of right anterior limbs with 2 Â 10 6 A549 human lung carcinoma cells, and then monitored daily for tumor growth. Tumor volume was measured with a caliper and calculated by the formula, tumor size ¼ ab 2 /2, where a is the larger and b is the smaller of the two dimensions. When the tumors grew up to a mean tumor volume of around 0.1 cm 3 , the A549 human lung carcinoma xenografted tumor-bearing mice were intratumorally injected with PBS (PBS control) or 1 Â 10 8 GTU of Ad-ING4-IL-24, Ad-ING4, Ad-IL-24 and Ad every other day for a total of six times, respectively. Tumor progression and regression was monitored and tumor volume was measured daily. In addition, the tumor-bearing mice (six each group) were killed 20 days after treatment, and the xenografted tumors were removed, weighted, fixed by 10% neutral formalin and embedded in paraffin for Hematoxylin & Eosin staining and immunohistochemistric analysis.
Immunohistochemistric analysis
The expression of CD34 in A549 human lung carcinoma s.c. xenografted tumors was tested by immunohistochemistric analysis using UltraSensitiveTM SP kit according to the company's protocol. The presence of buffy or brown diaminobenzidine precipitates is indicative of positive reactivity. The integral optical density of immunohistochemical intensity was then calculated by Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD). Microvessel density (MVD), detected by immunostaining for CD34, was determined as previously described by Weidner.
29 Any endothelial cell cluster immunoreactive for CD34 clearly separated from adjacent microvessels was considered as a single countable vessel. Each value represents integral optical density or microvessels counted at a high-power view ( Â 400) by microscopy. The mean value represents for the average number derived from five high-power fields of each case.
Evaluation of combinatorial interaction
The interactive effects of ING4 and IL-24 by adenovirusmediated ING4 and IL-24 coexpression were evaluated by Q-value calculated by the formula, 30 
Statistical analysis
All data are presented as the mean values±s.d. The significance of the difference between groups was evaluated by one-way and two-way repeated measures analysis of variance (ANOVA) and multiple comparisons with SPSS 10.0 software (SPSS, Chicago, IL). A value of Po0.05 was considered statistically significant.
Results
Adenovirus-mediated ING4 and IL-24 coexpression
We previously reported that adenovirus-mediated maximal transgene expression in A549 human lung carcinoma cells can be obtained using the dose of MOI of 100. 
Ad-ING4-IL-24 cooperatively regulates extrinsic and intrinsic apoptotic pathways
To further address the underlying molecular mechanism responsible for Ad-ING4-IL-24-induced enhanced 
Discussion
Multigene-based combination therapy represents an effective practice in cancer gene therapy, which can achieve greater therapeutic benefit by targeting multiple pathways. 31 Recent studies have reported that tumor suppressor ING4 has an important role in many cancerrelated cellular, implying that it is a potent tumor suppressor for cancer therapy. Expanding studies have demonstrated that the other tumor suppressor IL-24 as a cytokine-tumor suppressor can discriminate between normal and tumor cells, induce apoptosis, inhibit tumor angiogenesis, stimulate immune responses, promote bystander antitumor activity and synergize with anticancer drugs and radiation, suggesting it is also an effective agent for cancer treatment. However, the therapeutic effect of combination treatment with ING4 and IL-24 for cancer is still not reported. P53 as a transcription factor is an important tumor suppressor that can induce a permanent inhibition of cell growth through blocking cell cycle and activating apoptosis.
32 P21 and P27, important members of cyclindependent kinase inhibitors belonging to Cip/Kip family, can induce G1 and G2/M arrest. [33] [34] [35] There are at least two broad pathways leading to apoptosis: one elicited by extrinsic apoptotic pathway and the other by intrinsic apoptotic pathway. Fas as important apoptotic marker has been shown to regulate the cleavage of Caspase-8 leading to activation of extrinsic apoptotic pathway. 36 The ratio of anti-to pro-apoptotic Bcl-2 family molecules such as Bcl-2/Bax constitutes a rheostat that sets the threshold of susceptibility to apoptosis for the intrinsic pathway, including pore formation in the mitochondrial outer membrane, loss of mitochondrial integrity and the release of cytochrome c into the cytosol followed by the cleavage of Caspase-9. 36 To elucidate the underlying mechanism involved in ING4/IL-24 bicistronic adenovirus Ad-ING4-IL-24-mediated enhanced antitumor activity, the expression of cell cycle-and apoptosisrelated proteins such as P53, P21, P27, Fas, Bcl-2, Bax, Caspase-8, Caspase-9 and Caspase-3 in A549 human lung carcinoma cells was assessed by western blot analysis. We demonstrated that adenovirus-mediated ING4 and IL-24 coexpression elicited a cooperative and overlapping effect on upregulation of P21, P27, Fas, Bax and cleaved 9 suggesting that adenovirusmediated ING4 and IL-24 coexpression initiates enhanced tumor growth inhibition and apoptosis in the wild-type p53 tumor model such as our A549 NSCLC very possibly via their coordinate and functional links to P53. In addition, the progressive growth and metastasis of solid tumors are dependent upon the process of angiogenesis. It has been shown that ING4 can suppress tumor angiogenesis via downregulation of IL-8 and osteopontin proangiogenic factors through inhibiting the activity of nuclear factor kB and hypoxia-inducible factor-1a. 5, 14 It has also been reported that IL-24 can inhibit tumor angiogenesis via directly interacting with IL-22R1/IL-20R2 heterodimeric receptor on vascular endothelial cells 22 and indirectly reducing proangiogenic factors' production. 21, 23, 24 To explore the combined effect of adenovirusmediated ING4 and IL-24 coexpression on tumor angiogenesis in vivo, the MVD in A549 human lung carcinoma s.c. xenografted tumor tissues was determined by CD34 immunohistochemistric analysis. We further found that Ad-ING4-IL-24 additively downregulated CD34 expression and decreased MVD in A549 lung carcinoma xenografted tumors, which may be another important mechanism involved in Ad-ING4-IL-24-mediated in vivo enhanced growth inhibition of A549 lung carcinoma xenografted tumors in an athymic nude mouse model. 
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